News & Events
-
September 29, 2021
Volumetric MRI-Based Biomarkers in Huntington’s Disease: An Evidentiary Review
C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based biomarkers in HD.
-
August 23, 2021
ePRO Consortium Welcomes Medable
C-Path is proud to welcome Medable, Inc as the newest member of its Electronic Patient-Reported Outcome Consortium. Comprised of 14 firms that provide electronic data collection technologies and services for capturing patient-reported outcome and other clinical outcome assessment data in clinical trials, ePRO Consortium members collaborate in a pre-competitive environment to support and conduct novel research, design and deliver educational resources, and develop and disseminate best practice recommendations for the electronic collection of clinical outcome data. Welcome aboard, Medable!
-
August 17, 2021
Celebrating National Nonprofit Day and Sharing C-Path Updates
As we observe National Nonprofit Day and recognize the invaluable effort nonprofits put towards making an impact in our communities and across the globe, this seemed like a perfect opportunity to reshare some of the year’s accomplishments, championed by the talented and unshakeable team at C-Path, our consortia members and collaborators. Read our August 2021...... -
June 28, 2021
REQUEST FOR PROPOSAL: OMOP CDM Mapping, Training, and Consulting
C-Path’s Data Collaboration Center’s Data Science Team is seeking proposals from U.S.-based vendors to provide expertise and on-demand services related to the Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) for our rare disease data sharing platform, the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP). We...... -
May 19, 2021
ERA4TB Update
NEWSLETTER: The ERA4TB (European Regimen Accelerator for Tuberculosis) project, a public-private initiative devoted to accelerating the development of new treatment regimens for tuberculosis, issued its first newsletter this month which includes updates on the project thus far. Read the full communication and subscribe, here: https://era4tb.org/newsletter.